Amgen Inc.
Heterodimeric Bispecific Antibodies
Last updated:
Abstract:
Provided herein are heterodimeric bispecific antibodies that can mediate cytolysis of a target cell by an immune effector cell, nucleic acids encoding such antibodies, methods of making such antibodies, and methods of using such antibodies. These antibodies comprise two different polypeptide chains, each comprising two immunoglobulin variable regions and, optionally, a half life-extending moiety.
Status:
Application
Type:
Utility
Filling date:
12 Apr 2019
Issue date:
5 Mar 2020